» Articles » PMID: 29584889

Longitudinal Assessment of Illnesses, Stress Dosing, and Illness Sequelae in Patients With Congenital Adrenal Hyperplasia

Overview
Specialty Endocrinology
Date 2018 Mar 28
PMID 29584889
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Patients with congenital adrenal hyperplasia (CAH) are at risk for life-threatening adrenal crises. Management of illness episodes aims to prevent adrenal crises.

Objective: We evaluated rates of illnesses and associated factors in patients with CAH followed prospectively and receiving repeated glucocorticoid stress dosing education.

Methods: Longitudinal analysis of 156 patients with CAH followed at the National Institutes of Health Clinical Center over 23 years was performed. The rates of illnesses and stress-dose days, emergency room (ER) visits, hospitalizations, and adrenal crises were analyzed in relation to phenotype, age, sex, treatment, and hormonal evaluations.

Results: A total of 2298 visits were evaluated. Patients were followed for 9.3 ± 6.0 years. During childhood, there were more illness episodes and stress dosing than adulthood (P < 0.001); however, more ER visits and hospitalizations occurred during adulthood (P ≤ 0.03). The most robust predictors of stress dosing were young age, low hydrocortisone and high fludrocortisone dose during childhood, and female sex during adulthood. Gastrointestinal and upper respiratory tract infections (URIs) were the two most common precipitating events for adrenal crises and hospitalizations across all ages. Adrenal crisis with probable hypoglycemia occurred in 11 pediatric patients (ages 1.1 to 11.3 years). Undetectable epinephrine was associated with ER visits during childhood (P = 0.03) and illness episodes during adulthood (P = 0.03).

Conclusions: Repeated stress-related glucocorticoid dosing teaching is essential, but revised age-appropriate guidelines for the management of infectious illnesses are needed for patients with adrenal insufficiency that aim to reduce adrenal crises and prevent hypoglycemia, particularly in children.

Citing Articles

Life With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency: Challenges and Burdens.

Witchel S, Miller T, McCann E, Gupta A J Clin Endocrinol Metab. 2025; 110(Supplement_1):S56-S66.

PMID: 39836616 PMC: 11749882. DOI: 10.1210/clinem/dgae728.


Mental Health Issues Associated With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.

Sandberg D, Gardner M, Lapham Z J Clin Endocrinol Metab. 2025; 110(Supplement_1):S46-S55.

PMID: 39836615 PMC: 11749910. DOI: 10.1210/clinem/dgae668.


Temporal Trends in Acute Adrenal Insufficiency Events in Children With Congenital Adrenal Hyperplasia During 2019-2022.

Tseretopoulou X, Ali S, Bryce J, Amin N, Atapattu N, Bachega T J Endocr Soc. 2024; 8(10):bvae145.

PMID: 39258010 PMC: 11387114. DOI: 10.1210/jendso/bvae145.


Comparison of modified-release hydrocortisone capsules versus prednisolone in the treatment of congenital adrenal hyperplasia.

Rees D, Merke D, Arlt W, Brac de la Perriere A, Linden Hirschberg A, Juul A Endocr Connect. 2024; 13(8).

PMID: 38934378 PMC: 11301537. DOI: 10.1530/EC-24-0150.


Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia.

Auchus R, Hamidi O, Pivonello R, Bancos I, Russo G, Witchel S N Engl J Med. 2024; 391(6):504-514.

PMID: 38828955 PMC: 11309900. DOI: 10.1056/NEJMoa2404656.


References
1.
White K, Arlt W . Adrenal crisis in treated Addison's disease: a predictable but under-managed event. Eur J Endocrinol. 2009; 162(1):115-20. DOI: 10.1530/EJE-09-0559. View

2.
Merke D, Poppas D . Management of adolescents with congenital adrenal hyperplasia. Lancet Diabetes Endocrinol. 2014; 1(4):341-52. PMC: 4163910. DOI: 10.1016/S2213-8587(13)70138-4. View

3.
Repping-Wuts H, Stikkelbroeck N, Noordzij A, Kerstens M, Hermus A . A glucocorticoid education group meeting: an effective strategy for improving self-management to prevent adrenal crisis. Eur J Endocrinol. 2013; 169(1):17-22. DOI: 10.1530/EJE-12-1094. View

4.
Bornstein S, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer G . Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016; 101(2):364-89. PMC: 4880116. DOI: 10.1210/jc.2015-1710. View

5.
Nandagopal R, Sinaii N, Avila N, Van Ryzin C, Chen W, Finkielstain G . Phenotypic profiling of parents with cryptic nonclassic congenital adrenal hyperplasia: findings in 145 unrelated families. Eur J Endocrinol. 2011; 164(6):977-84. PMC: 3470911. DOI: 10.1530/EJE-11-0019. View